# Nanjing Superyears Gene Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nanjing-superyears-gene-technology-co

- Industry: Medical Devices & Equipment
- Headquarters: Nanjing, China
- Website: www.superyears.com
- Total disclosed funding: $8.2M
- Latest round: Series A (Sep 24, 2023)
- Investors on record: 3

## About

Established in 2017 and based in Nanjing, China, Nanjing Superyears Gene Technology Co., Ltd. operates as a biotechnology company that focuses on life science instruments R&D and manufacturing. It has passed ISO9001 and ISO13485 quality management system certification. In December 2019, the company was recognized as a high-tech enterprise. In 2020, it developed a real-time fluorescence quantitative PCR instrument. In September 2023, the company raised over CNY 60 million in series A funding from Oct Capital, Anhui Guokong Capital Private Equity Fund Management and Park Pugo Industrial Fund.

The company engages in the research and development of life science instruments. Its products include the Classic series genetic analyzer, Honor series forensic genetic analyzer, real-time fluorescence PCR instrument, gradient PCR instrument and nucleic acid extractor.

## Funding rounds

- Series A, Sep 24, 2023, $8.2M — October Capital, Anhui Guokong Capital Private Equity Fund Management, Park Pugo Industrial Fund

## Investors

- October Capital (https://capitalatlas.ai/funds/october-capital) — Series A
- Anhui Guokong Capital Private Equity Fund Management (https://capitalatlas.ai/funds/anhui-guokong-capital-private-equity-fund-management) — Series A
- Park Pugo Industrial Fund — Series A